Detalhe da pesquisa
1.
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
Chron Respir Dis;
20: 14799731231202257, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37800633
2.
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial.
Respir Res;
22(1): 279, 2021 Oct 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34711232
3.
Long-term safety and efficacy studies of epinephrine HFA metered-dose inhaler (Primatene® Mist): a two-stage randomized controlled trial.
J Asthma;
58(5): 633-644, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31959019
4.
Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD.
Pulm Pharmacol Ther;
60: 101873, 2020 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31841699
5.
Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective.
Respir Res;
20(1): 141, 2019 Jul 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31286970
6.
Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study.
Respir Res;
20(1): 167, 2019 Jul 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31358008
7.
Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial.
Respir Res;
20(1): 238, 2019 Oct 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31666084
8.
Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study.
Eur Respir J;
52(3)2018 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30220648
9.
A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD.
Respir Res;
19(1): 38, 2018 03 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29506504
10.
A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Res;
18(1): 8, 2017 01 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28061907
11.
Randomized, dose-ranging study of a fluticasone propionate multidose dry powder inhaler in adolescents and adults with uncontrolled asthma not previously treated with inhaled corticosteroids.
J Asthma;
54(1): 89-98, 2017 01 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27285965
12.
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD.
Respir Res;
17(1): 109, 2016 09 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27586537
13.
Safety and efficacy of beclomethasone dipropionate delivered by breath-actuated or metered-dose inhaler for persistent asthma.
Allergy Asthma Proc;
37(5): 359-69, 2016 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27510595
14.
A Preference Study of Two Placebo Dry Powder Inhalers in Adults with COPD: ELLIPTA® Dry Powder Inhaler (DPI) versus DISKUS® DPI.
COPD;
13(2): 167-75, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26516724
15.
Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study.
Respir Res;
15: 123, 2014 Oct 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25756831
16.
Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients.
J Allergy Clin Immunol;
131(2): 339-45, 2013 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23174659
17.
Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Res;
18(1): 158, 2017 08 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28826397
18.
Efficacy of indacaterol 75 µg once-daily on dyspnea and health status: results of two double-blind, placebo-controlled 12-week studies.
COPD;
9(6): 629-36, 2012 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23020650
19.
Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I).
COPD;
9(2): 90-101, 2012 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22320148
20.
Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD.
Respir Med;
200: 106918, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35803172